These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 2052117)

  • 1. [Lithium in the treatment of chronic alcoholic patients with brain damage--a controlled study].
    Olbrich R; Watzl H; Völter M; Siedow H
    Nervenarzt; 1991 Mar; 62(3):182-6. PubMed ID: 2052117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient characteristics and treatment implications of marijuana abuse among bipolar alcoholics: results from a double blind, placebo-controlled study.
    Salloum IM; Cornelius JR; Douaihy A; Kirisci L; Daley DC; Kelly TM
    Addict Behav; 2005 Oct; 30(9):1702-8. PubMed ID: 16098680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM; Levin FR; Brooks DJ; Garawi F
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [alpha-beta L-aspartate magnesium in treatment of chronic benzodiazepine abuse: controlled and double-blind study versus placebo].
    Hantouche EG; Guelfi JD; Comet D
    Encephale; 1998; 24(5):469-79. PubMed ID: 9850822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatments for alcoholism: revisiting lithium and considering buspirone.
    Fawcett J; Kravitz HM; McGuire M; Easton M; Ross J; Pisani V; Fogg LF; Clark D; Whitney M; Kravitz G; Javaid J; Teas G
    Alcohol Clin Exp Res; 2000 May; 24(5):666-74. PubMed ID: 10832908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospective study of favorable factors in follow-up of drug addicted patients--apropos of 257 patients of the Cassini Center in Paris].
    Goeb JL; Coste J; Bigot T; Ferrand I
    Encephale; 2000; 26(6):11-20. PubMed ID: 11217533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcoholism and depression: a placebo controlled study with viloxazine.
    Altamura AC; Mauri MC; Girardi T; Panetta B
    Int J Clin Pharmacol Res; 1990; 10(5):293-8. PubMed ID: 2079386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Sorge J; Sittl R
    Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence.
    Mueller TI; Stout RL; Rudden S; Brown RA; Gordon A; Solomon DA; Recupero PR
    Alcohol Clin Exp Res; 1997 Feb; 21(1):86-92. PubMed ID: 9046378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of angiotensin II synthesis inhibition on alcohol consumption].
    Guivernau M; Pallavicini J
    Rev Med Chil; 2008 Aug; 136(8):968-75. PubMed ID: 18949179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological impairment in alcoholics.
    Shaw GK; Spence M
    Alcohol Alcohol; 1985; 20(2):243-9. PubMed ID: 4052159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan.
    Huang MC; Chen CH; Yu JM; Chen CC
    Addict Biol; 2005 Sep; 10(3):289-92. PubMed ID: 16109592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.